Online Database of Chemicals from Around the World

(7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester
[CAS# 95716-70-4]

Top Active Suppliers
Hangzhou Verychem Science And Technology Co., Ltd. China Inquire  
+86 (571) 8816-2785
+86 13606544505
lucy@verychem.com
Chemical manufacturer since 2004
chemBlink massive supplier since 2021
Simagchem Corporation China Inquire  
+86 13806087780
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2008
Manus Aktteva India Inquire  
+91 (79) 6512-3395
products@manusakttevabiopharma.in
Chemical distributor
chemBlink standard supplier since 2008
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Biosyn Healthy Pharma Co., Ltd. China Inquire  
+86 (22) 8386-5698
lhb19831230@gmail.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2012
Hangzhou Qichuang Chemical Co., Ltd. China Inquire  
+86 (571) 8893-5129
david@qc-chemical.com
sales@qc-chemical.com
davidw0828@gmail.com
QQ chat
Chemical distributor since 2009
chemBlink standard supplier since 2013
Hangzhou Shilo Pharmachem Co., Ltd. China Inquire  
+86 15258872085
sales@shilopharma.com
QQ chat
Chemical manufacturer since 2015
chemBlink standard supplier since 2015
Neostar United (Changzhou) Industrial Co., Ltd. China Inquire  
+86 (519) 8555-7386
+86 18015025600
marketing1@neostarunited.com
Chemical distributor since 2014
chemBlink standard supplier since 2020
Complete supplier list of (7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester
Identification
Classification Pharmaceutical intermediate >> API intermediate
Name (7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester
Synonyms delta9,11-Eplerenone; methyl (7R,8R,10S,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate
Molecular Structure CAS # 95716-70-4, (7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester, delta9,11-Eplerenone, methyl (7R,8R,10S,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate
Molecular Formula C24H30O5
Molecular Weight 398.49
CAS Registry Number 95716-70-4
EC Number 619-164-5
SMILES C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3C2=CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C)C(=O)OC
Properties
Density 1.2±0.1 g/cm3 Calc.*
Boiling point 580.2±50.0 ºC 760 mmHg (Calc.)*
Flash point 251.7±30.2 ºC (Calc.)*
Index of refraction 1.576 (Calc.)*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H317-H319    Details
Precautionary Statements P280-P305+351+338    Details
SDS Available
up Discovory and Applicatios
(1S,4S)-4-amino-1,2,3,4-tetrahydronaphthalen-1-ol is a chiral bicyclic amine–alcohol with a partially saturated naphthalene core bearing an amino group at C-4 and a hydroxyl at C-1. The molecule’s architecture combines a rigid, hydrogen-bonding framework with stereochemical complexity, making it a valuable intermediate in the preparation of bioactive compounds and ligands for asymmetric synthesis.

Its stereochemistry was originally established through enantioselective hydrogenation of substituted naphthalenones or via resolution of racemic precursors. Once synthesized, the amine and alcohol groups can be selectively manipulated, enabling the construction of functionalized derivatives. For example, the amino group may be derivatized via acylation, sulfonamide formation, or heterocycle synthesis, while the hydroxyl group can be converted into ethers, esters, or aldehydes under mild conditions, preserving the stereochemical integrity.

One of the compound’s most important applications lies in medicinal chemistry. The 1,2,3,4-tetrahydronaphthalene motif is found in several classes of pharmacologically active molecules, including central nervous system agents, enzyme inhibitors, and receptor ligands. The chiral amino-alcohol scaffold can impart specific three-dimensional interactions with biological targets, and its rigid bicyclic core supports favorable binding conformations. Researchers often use (1S,4S)-4-amino-1,2,3,4-tetrahydronaphthalen-1-ol as a building block in the synthesis of lead compounds for drug discovery.

Beyond drug design, the compound is used in asymmetric catalysis and ligand development. Its dual functionality—an amine and a secondary alcohol—enables coordination with metals, making it a candidate for chiral ligand frameworks. These ligands, in turn, support enantioselective transformations such as hydrogenation, cross-coupling, or addition reactions. The scaffold’s rigidity helps ensure high enantioselectivity by limiting conformational flexibility during catalysis.

In synthetic methodology, the compound is employed to probe stereochemical outcomes and functional-group interconversions. By using protecting groups on the amine or hydroxyl, chemists can selectively activate one site for reaction while preserving the other. The scaffold’s defined chirality also allows detailed investigation of reaction mechanisms, such as stereoretentive versus stereoinvertive transformations, or the influence of stereochemistry on reactivity and regioselectivity.

Physically, (1S,4S)-4-amino-1,2,3,4-tetrahydronaphthalen-1-ol is typically isolated as a crystalline or viscous solid. It is moderately soluble in polar organic solvents such as methanol, ethanol, and dimethyl sulfoxide, but less soluble in nonpolar media. The compound is stable under standard laboratory conditions but should be protected from strong acids or bases, which could protonate or deprotonate its functional groups and potentially lead to racemization or degradation.

Overall, (1S,4S)-4-amino-1,2,3,4-tetrahydronaphthalen-1-ol is a synthetically and pharmaceutically useful chiral building block. Its rigid bicyclic scaffold and dual functional groups make it an attractive intermediate for drug design, asymmetric catalysis, and chemical methodology.

References

Eplerenone (2011) Pharmaceutical Substances. Thieme Medical Publishers, New York. (Monograph entry: Eplerenone) Link

Process to prepare eplerenone (2003) US Patent Application US-2003232981-A1. Priority date 22 March 2002. Link

Preparation method and intermediate of eplerenone (2013) Chinese Patent CN-102276684-B. Priority date 08 June 2010. Grant date 10 April 2013. Link
Market Analysis Reports
List of Reports Available for (7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester
Related Products
N-[(3beta)-3-Hydroxy-28-oxoolean-12-en-28-yl]-L-leucine  N-[(3beta)-3-Hydroxy-28-oxoolean-12-en-28-yl]-L-phenylalanine  N-[(3beta)-3-Hydroxy-28-oxoolean-12-en-28-yl]-L-proline  5-Hydroxy-3-oxopentanoic acid ethyl ester  [mu-(7-Hydroxy-3-oxo-3H-phenoxazine-4,6-diyl)]bis(2,2,2-trifluoroacetato)dimercury  (6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester  4-Hydroxy-3-[3-oxo-1-(phenyl-D5)butyl]-2H-1-benzopyran-2-one  N-[[4-Hydroxy-2-oxo-1-(phenylmethyl)-1,2-dihydro-3-quinolinyl]carbonyl]glycine  N-[(2S)-2-Hydroxy-1-oxo-3-phenylpropyl]-L-tyrosine  1-Hydroxy-2-oxopomolic acid  (4R)-3-[(2R,3S)-3-Hydroxy-1-oxo-2-(2-propen-1-yl)-4-penten-1-yl]-4-(phenylmethyl)-2-oxazolidinone  alpha-[6-Hydroxy-6-oxido-1,12-dioxo-9-[(1-oxooctadecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphanonacos-1-yl]-omega-methoxy-poly(oxy-1,2-ethanediyl)  alpha-[(9R)-6-Hydroxy-6-oxido-1,12-dioxo-9-[(1-oxooctadecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphanonacos-1-yl]-omega-methoxypoly(oxy-1,2-ethanediyl) ammonium salt  alpha-[(9R)-6-Hydroxy-6-oxido-1,12-dioxo-9-[(1-oxotetradecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphapentacos-1-yl]-omega-methoxypoly(oxy-1,2-ethanediyl) ammonium salt  4-Hydroxy-alpha-oxobenzeneacetaldehyde  (alphaS)-alpha-Hydroxy-gamma-oxobenzenebutanoic acid ethyl ester  (alphaR)-alpha-Hydroxy-gamma-oxobenzenebutanoic acid ethyl ester  4-Hydroxy-beta-oxobenzenepropanoic acid ethyl ester  5-Hydroxy-4-oxo-4H-1-benzopyran-2-carboxylic acid  5-Hydroxy-4-oxo-4H-1-benzopyran-2-carboxylic acid ethyl ester